Get 40% Off
🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

5 Best And Worst Performing Mega-Cap Stocks

Published 07/03/2022, 12:36 AM

Mega-cap stocks (those with a market cap of more than $200 billion) are known to be stable. However, tightening monetary policies, multi-decade high inflation, rising commodities prices, geopolitical tensions, and concerns over economic growth have made even these stocks relatively more volatile than usual on the negative side. In June, there were only a few mega-cap stocks that were in the green. Let’s take a look at the five best and worst performing mega-cap stocks in June 2022.

Five Best Performing Mega-Cap Stocks In June 2022

We have used the monthly return data (from finviz.com) to come up with the five best and worst performing mega-cap stocks in June 2022. First, let’s take a look at the five best performing mega-cap stocks in June 2022.

5. Pepsico (-1%)

Founded in 1965 and headquartered in Purchase, N.Y., PepsiCo (NASDAQ:PEP) shares are down by over 4% year to date and by almost 1% in the last three months. The company reported revenue of more than $79 billion in 2021 and over $70 billion in 2020. As of writing, PepsiCo shares were trading at over $166, and have a 52-week range of $147.77 to $177.62

4. Costco (3%)

Founded in 1983 and headquartered in Issaquah, Wash., Costco (NASDAQ:COST) operates a chain of membership-only big-box retail stores. The shares are down by over 15% year to date and by almost 17% in the last three months. The company reported revenue of more than $190 billion in 2021 and over $160 billion in 2020. As of writing, Costco Wholesale shares were trading at over $478, and have a 52-week range of $393.88 to $612.27.

3. UnitedHealth (3%)

Founded in 1977 and headquartered in Minnetonka, Minn., UnitedHealth (NYSE:UNH) offers health care coverage, software, and data consultancy services. The shares are up by over 2% year to date and by almost 1% in the last three months. The company reported revenue of more than $280 billion in 2021 and over $250 billion in 2020. As of writing, UnitedHealth Group shares were trading at over $510, and have a 52-week range of $383.12 to $553.29.

2. Eli Lily (3%)

Founded in 1876 and headquartered in Indianapolis, Ind., Eli Lilly (NYSE:LLY) deals in pharmaceutical products, including Diabetes, Oncology, Immunology, Neuroscience, and Other therapies. The shares are up by over 17% year to date andby over 13% in the last three months. The company reported revenue of more than $28 billion in 2021 and over $23 billion in 2020. As of writing, Eli Lilly shares were trading at over $325, and have a 52-week range of $220.20 to $330.85.

AbbVie (4%)

Founded in 2011 and headquartered in North Chicago, Ill., AbbVie (NYSE:ABBV) is a biopharmaceutical firm that develops and sells pharmaceutical products. The shares are up by over 13% year to date but are down by over 4% in the last three months. The company reported revenue of more than $56 billion in 2021 and over $45 billion in 2020. As of writing, AbbVie shares were trading at over $152, and have a 52-week range of $105.56 to $175.91.

Five Worst Performing Mega-Cap Stocks In June 2022

JP Morgan (-15%)

Founded in 1968 and headquartered in New York City, JPMorgan (NYSE:JPM) is a financial holding company that provides financial and investment banking services. The shares are down by almost 29% year to date and by over 17% in the last three months. The company reported revenue of more than $57 billion in 2021 and over $64 billion in 2020. As of writing, JPMorgan Chase shares were trading at over $112, and have a 52-week range of $110.93 to $172.96

Bank of America (-16%)

Founded in 1904 and headquartered in Charlotte, N.C., Bank of America (NYSE:BAC) offers banking and nonbanking financial services. The shares are down by over 30% year to date and over 24% in the last three months. The company reported revenue of more than $47 billion in 2021 and over $51 billion in 2020. As of writing, Bank of America shares were trading at over $31, and have a 52-week range of $30.64 to $50.11.

Meta Platforms (-17%)

Founded in 2004 and headquartered in Menlo Park, Calif., Meta Platforms (NASDAQ:META) develops and operates social media applications. The shares are down by over 52% year to date and by over 25% in the last three months. It reported revenue of more than $117 billion in 2021 and over $85 billion in 2020. As of writing, Meta Platforms shares were trading at over $160, and have a 52-week range of $154.25 to $384.33.

Chevron (-17%)

Founded in 1906 and headquartered in San Ramon, Calif., Chevron (NYSE:CVX) provides administrative, financial management, and technology support for energy and chemical operations. The shares are up by over 23% year to date but are down by over 11% in the last three months. The company reported revenue of more than $150 billion in 2021 and over $90 billion in 2020. As of writing, Chevron shares were trading at over $145, and have a 52-week range of $92.86 to $182.40.

NVIDIA (-18%)

Founded in 1993 and headquartered in Santa Clara, Calif., NVIDIA (NASDAQ:NVDA) offers computer graphics processors, chipsets, and related software. The shares are up by over 48% year to date and by over 44% in the last three months. The company reported revenue of more than $26 billion in 2021 and over $16 billion in 2020. As of writing, NVIDIA shares were trading at over $149, and have a 52-week range of $148.62 to $346.47.

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.